SCHEMBL3816261

SCHEMBL3816261

C[C@H](NC(=O)C1(C)CC1)C(Oc1ccc2c(cnn2-c2ccc(F)cc2)c1)c1cccc(F)c1

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 20/20 0.68
PGR P06401 3/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL835723 1.00 NR3C1 (0.68) NR3C1PGR
SCHEMBL835724 1.00 NR3C1 (0.68) NR3C1PGR
SCHEMBL836226 0.94 NR3C1 (0.66) NR3C1PGR
SCHEMBL836227 0.94 NR3C1 (0.66) NR3C1PGR
SCHEMBL3806799 0.93 NR3C1 (0.65) NR3C1PGR
SCHEMBL836986 0.93 NR3C1 (0.65) NR3C1PGR
SCHEMBL836987 0.93 NR3C1 (0.65) NR3C1PGR
SCHEMBL836709 0.90 NR3C1 (0.63) NR3C1PGR
SCHEMBL836710 0.90 NR3C1 (0.63) NR3C1PGR
SCHEMBL3811632 0.90 NR3C1 (0.63) NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142588-A1 COMBINATION OF (A) A CHEMOKINE RECEPTOR 1 (CCR1) ANTAGONIST AND (B) GLUCOCORTICOID RECEPTOR MODULATOR ASTRAZENECA AB (SE) 2009-11-26 WO disclosed
WO-2009142568-A1 COMBINATION OF (A) GLUCOCORTICOID RECEPTOR MODULATOR AND (B) A B2-AGONIST ASTRAZENECA AB (SE) 2009-11-26 WO disclosed
WO-2009142589-A1 COMBINATION OF (A) GLUCOCORTICOID RECEPTOR MODULATOR AND (B) A MUSCARINIC ANTAGONIST ASTRAZENECA AB (SE) 2009-11-26 WO disclosed
EP-2102169-A1 INDAZOLYL ESTER AND AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS AstraZeneca AB (SE) 2009-09-23 EP disclosed
WO-2008076048-A1 INDAZOLYL ESTER AND AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2008-06-26 WO disclosed